Assessment of the Use of Pharmacologic Venous Thromboembolism Prophylaxis in Post-Traumatic Brain Injury Patients

Abstract

Background:

Traumatic brain injury (TBI) is an independent risk factor for venous thromboembolism (VTE). Prophylaxis (PPX) beyond 48 hours increases VTE risk 3- to 4-fold. Pharmacologic VTE PPX initiation is controversial due to potential bleeding complications.

Objective:

To evaluate VTE PPX in patients with TBI for practice variation, efficacy, and safety.

Methods:

Retrospective review from January 2013 to September 2016 in adults admitted to the intensive care unit with moderate to severe TBI. Demographics, time to stable computerized tomography scan, time to PPX initiation, PPX regimen, and incidences of VTE and adverse effects were collected. Data were analyzed via descriptive statistics, analysis of variance, and linear regression models.

Results:

Of 96 patients included, 14.6% did not receive VTE PPX (G1), 7.3% initiated therapy within 0 to 24 hours (G2), 14.6% after 24 to 48 hours (G3), and 63.5% after 48 hours (G4). VTE occurred in 0% of G1 and G2, 28.6% of G3, and 8.2% of G4 patients (P = .038). Of 9 VTE cases, 8 received medical and 1 received trauma PPX dosing (P = .44). There were 3 major bleeds (P = .79) and 19 minor bleeds (P = .042). Of 14 fatalities, 42.9% were in G1, 0% in G2, 14.2% in G3, and 42.9% in G4 (P = .009).

Conclusion:

The majority of patients received delayed PPX, with no correlation between VTE incidence and PPX regimen. There was a significant difference in VTE incidence stratified by time to PPX. Further studies are required to determine optimal timing of PPX. Higher mortality rate was correlated with the lack of PPX. Increased minor bleeds occurred with earlier PPX initiation.

Keywords

traumatic brain injury venous thromboembolism prophylaxis intracranial hemorrhage trauma

Get full access to this article

View all access options for this article.

References

Gearhart

Luchette

Proctor

, et al. The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis. Surgery. 2000;128(4):631–640. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/11015097. doi:10.1067/msy.2000.108224

Geerts

Code

Jay

, et al. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331(24):1601–1606. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/7969340. doi: 10.1056/nejm199412153312401.

Reiff

Haricharan

Bullington

, et al. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma. 2009;66(5):1436–1440. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/19430251. doi:10.1097/TA.0b013e31817fdf1c.

Mohseni

Talving

Lam

, et al. Venous thromboembolic events in isolated severe traumatic brain injury. J Emerg Trauma Shock. 2012;5(1):11–15. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/22416148; PubMed Central PMCID: PMCPMC3299146. doi:10.4103/0974-2700.93102.

Nathens

McMurray

Cuschieri

, et al. The practice of venous thromboembolism prophylaxis in the major trauma patient. J Trauma. 2007;62(3):557–562; discussion 62-3. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/1741432817414328. doi:10.1097/TA.0b013e318031b5f5.

Nyquist

Bautista

Jichici

, et al. Prophylaxis of venous thrombosis in neurocritical care patients: An Evidence-based guideline: a Statement for healthcare professionals from the neurocritical care society. Neurocrit Care. 2016;24(1):47–60. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/2664611826646118. doi: 10.1007/s12028-015-0221-y.

Gould

Garcia

Wren

, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl): e227S–e277S. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/22315263; PubMed Central PMCID: PMCPMC3278061. doi:10.1378/chest.11-2297.

Guyatt

Akl

Crowther

, et al. Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):7s–47s. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/22315257; PubMed Central PMCID: PMCPMC3278060. doi:10.1378/chest.1412S3.

Rogers

Cipolle

Velmahos

, et al. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: The EAST Practice Management Guidelines Work Group. J Trauma. 2002;53(1):142–164. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/12131409.

10.

Carney

Totten

O’Reilly

, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80(1):6–15. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/27654000. doi:10.1227/neu.0000000000001432.

11.

Schulman

Kearon

. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–694. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/1584235415842354. doi:10.1111/j.1538-7836.2005.01204.x.

12.

Scudday

Brasel

Webb

, et al. Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury. J Am Coll Surg. 2011;213(1):148–153; discussion 53-4. Epub 2011/04/05. doi: 10.1016/j.jamcollsurg.2011.02.027. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/21459632.

13.

Strollo

Bennett

Chopko

, et al. Timing of venous thromboembolism chemoprophylaxis after traumatic brain injury. J Crit Care. 2018;43:75–80. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/288509312. doi:10.1016/j.jcrc.2017.08.012.

14.

Jamjoom

Chari

Salijevska

, et al. A national survey of thromboprophylaxis in traumatic brain injury in the United Kingdom. Br J Neurosurg. 2016;30(2):240–245. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/26999404. doi:10.3109/02688697.2016.1161170.

15.

MacLeod

Lynn

McKenney

, et al. Predictors of mortality in trauma patients. Am Surg. 2004;70(9):805–810. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/15481299.

16.

Kuhls

Malone

McCarter

, et al. Predictors of mortality in adult trauma patients: the physiologic trauma score is equivalent to the Trauma and Injury Severity Score. J Am Coll Surg. 2002;194(6):695–704. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/12081059. doi:10.1016/s1072-7515(02)01211-5.

17.

Mesa Galan

Egea-Guerrero

Quintana Diaz

, et al. The effectiveness and safety of pharmacological prophylaxis against venous thromboembolism in patients with moderate to severe traumatic brain injury: a systematic review and meta-analysis. J Trauma Acute Care Surg. 2016;81(3):567–574. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/27244574. doi:10.1097/ta.0000000000001134.

18.

Byrne

Mason

Gomez

, et al. Timing of pharmacologic venous thromboembolism prophylaxis in severe traumatic brain injury: a propensity-matched cohort study. J Am Coll Surg. 2016;223(4):621–631.e5. PubMed PMID: http://www.ncbi.nlm.nih.gov/pubmed/27453296. doi:10.1016/j.jamcollsurg.2016.06.382.